World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614000487617
Date of registration: 09/05/2014
Prospective Registration: Yes
Primary sponsor: Hopital Militaire Principal d'Instruction de Tunis
Public title: Is bispectral index monitoring useful to assess the quality of analgesia in patients under general anesthesia?
Scientific title: Induction of general anesthesia and laryngoscopy with and without remifentanil: can bispectral index predict and/or detect the lack of analgesia?
Date of first enrolment: 12/05/2014
Target sample size: 60
Recruitment status: Not yet recruiting
URL:  https://anzctr.org.au/ACTRN12614000487617.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Tunisia
Contacts
Name: Dr Abderrahmen Bargaoui   
Address:  Hopital Militaire de Tunis. Montfleury 1008 Tunis Tunisia
Telephone: +21622849078
Email: bargaoui.abd@gmail.com
Affiliation: 
Name: Mr Abderrahmen Bargaoui   
Address:  Hopital Militaire de Tunis. Montfleury 1008 Tunis Tunisia
Telephone: +21622849078
Email: bargaoui.abd@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: - ASA class 1 or 2.
- Proposed for elective surgery.

Exclusion criteria: - Predicted difficult intubation.
- Hard-to-control hypertension.
- Coronaropathy.


Age minimum: 18 Years
Age maximum: 70 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Anaesthesiology - Other anaesthesiology
General anesthesia;Analgesia;measuring depth of anesthesia;
General anesthesia
Analgesia
measuring depth of anesthesia
Intervention(s)
- Patients were randomized in 2 groups.
- Group P: induction of anesthesia performed by propofol alone.
- Group PR: induction of anesthesia performed by propofol and remifentanil.
- Propofol administration was performed in the 2 groups by target-controlled infusion (TCI) using Schnider model. We targeted a plasmatic concentration of 6ug/ml obtained over 2 minutes.
- Remifentanil administration was performed in the PR group by TCI using Minto model. We targeted a cerebral concentration of 4ng/ml.
- We noted the arterial pressure, heart rate and bispectral index (BIS) each minute.
- As BIS reached 60, consumption and cerebral concentration of propofol and time elapsed since the initiation of the induction were noted. Then, we fixed the plasmatic concentration of propofol to the cerebral concentration noted.
- A muscle relaxing agent was administered and a laryngoscopy with endotracheal intubation was performed.
- BIS, heart rate and arterial pressure were noted before and in the 2 minutes following laryngoscopy.
Primary Outcome(s)
Difference in DeltaBIS (maximum of BIS after laryngoscopy - BIS before laryngoscopy) between the P and the PR group.[2 minutes after laryngoscopy]
Secondary Outcome(s)
Correlation between DeltaBIS and DeltaArterialPressure. Arterial pressure is assessed by automated pneumatic cuff.[2 minutes after laryngoscopy]
Correlation between DeltaBIS and DeltaHeartRate. Heart rate is assessed by continuous electrocardiogram.[2 minutes after laryngoscopy]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Hopital Militaire Principal d'Instruction de Tunis
Secondary Sponsor(s)
Ethics review
Status: Not approved
Approval date:
Contact:
Comité d'ethique local de l'Hopital Militaire de Tunis
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history